Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Table of Contents

October 01, 2008; Volume 75,Issue 10

From the Editor

  • You have access
    When a quick sound bite won’t do
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 686;

    In the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, why did more patients die if they got intensive therapy than if they got standard therapy? In this issue of the Journal, an investigator in this trial gives his analysis.

The Clinical Picture

  • You have access
    A judgment call
    Deepak Asudani, MD, Sharon Wretzel, MD, Ruchita Patel, MD and Aaron Stayman, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 690-695;

    A young man hospitalized because of a sickle cell crisis requires a central venous line. However, after the catheter is inserted, an initial chest radiograph reveals that the tip may not be in the right place. What should be done?

Editorial

  • You have access
    Preventing renal disease progression: Can complete renin-angiotensin- aldosterone blockade work?
    Martin J. Schreiber, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 699-704;

    In view of the risks of complete blockade of the renin-angiotensin- aldosterone pathway, more data from clinical trials are needed before the general medical community widely applies this strategy to prevent progressive chronic kidney disease.

Review

  • You have access
    An update on proteinuric chronic kidney disease: The dual-goal approach
    Sheldon Hirsch, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 705-713;

    To slow the progression of proteinuric chronic kidney disease, we may need to set goals for lowering both blood pressure and urinary albumin excretion, using drugs that block the renin-angiotensin-aldosterone system at multiple sites or in higher doses. However, this dual-goal approach needs to be validated prospectively.

  • You have access
    Which patients benefit from carotid stenting? What recent trials show
    Mark Bain, MD, Asma M. Moheet, MD and Peter Rasmussen, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 714-720;

    Whether carotid stenting has any advantage over carotid surgery and which patients should undergo it are still topics of study and debate.

  • You have access
    Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
    Chin Hee Kim, MD and Zobair M. Younossi, MD, MPH
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 721-728;

    As we get heavier, our livers get fattier. Despite an explosion of research on nonalcoholic fatty liver disease and gains in understanding its epidemiology and pathogenesis, a number of issues remain unresolved, including how to treat it.

Interpreting Key Trials

  • You have access
    A Clinician and Clinical Trialist’s Perspective
    Byron J. Hoogwerf, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 729-737;

    Even though more people died in the intensive-treatment group than in the standard-treatment group, the results from this trial should not substantially alter our usual approach to glucose-lowering.

Review

  • Using biochemical markers of bone turnover in clinical practice
    You have access
    Using biochemical markers of bone turnover in clinical practice
    Frederick R. Singer, MD and David R. Eyre, PhD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 739-750;

    Although no guidelines to date recommend the widespread use of these markers in clinical practice, we believe they will eventually be accepted.

Editorial

  • You have access
    Biochemical markers of bone turnover: Useful but underused
    Angelo A. Licata, MD
    Cleveland Clinic Journal of Medicine October 2008, 75 (10) 751-752;

    Markers tell us the risk of fracture and are useful in patient management. But will insurance pay for testing?

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 75 (10)
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 10
1 Oct 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • The Clinical Picture
  • Editorial
  • Review
  • Interpreting Key Trials
  • Review
  • Editorial
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Mass under the lip
Fundic gland polyps: Should my patient stop taking PPIs?
Colovesical fistula in men with chronic urinary tract infection: A diagnostic challenge
Oral leukoplakia and oral cancer
A 50-year-old man presents with shortness of breath
Myasthenia gravis: Frequently asked questions
Central vision loss in a 44-year-old woman
Median rhomboid glossitis caused by tongue-brushing
Making best use of bone turnover markers to monitor oral bisphosphonate therapy
Asymptomatic granules on the buccal mucosa
Does my patient need to be screened or treated for a urinary tract infection?
Ignore e-cigarettes at your patient’s peril
Spontaneous oral hematoma diagnosed as angina bullosa hemorrhagica
Hypophosphatemia in a patient with an eating disorder

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire